Human intestinal P-glycoprotein activity estimated by the model substrate digoxin

Author： Larsen U. L.   Olesen Hyldahl   Nyvold Guldborg   Eriksen J.   Jakobsen P.   Østergaard M.   Autrup H.   Andersen V.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.67, Iss.2, 2007-01, pp. : 123-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P‐glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 2, 2018-02 ,pp. : 202-211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Itraconazole and clarithromycin inhibit P‐glycoprotein activity in primary human sinonasal epithelial cells

By  

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, Vol. 5, Iss. 6, 2015-06 ,pp. : 477-480

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacoresistance in Epilepsy: A Pilot PET Study with the P‐Glycoprotein Substrate R‐[11C]verapamil

By  

EPILEPSIA, Vol. 48, Iss. 9, 2007-09 ,pp. : 1774-1784

John Wiley & Sons Inc

Access to resources Recommend Favorite

Geneva Cocktail for Cytochrome P450 and P‐Glycoprotein Activity Assessment Using Dried Blood Spots

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 3, 2014-09 ,pp. : 349-359

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P‐glycoprotein

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 1010-1023

John Wiley & Sons Inc

Access to resources Recommend Favorite